Zacks Investment Research on MSN

Robust TAVR Growth to Drive Edwards Lifesciences' Q3 Earnings

Edwards Lifesciences Corp. EW is scheduled to report third-quarter 2025 results on Oct. 30, after market close. In the last ...

Edwards Lifesciences: Inflection Incoming, But When?

Edwards Lifesciences remains a market leader in transcatheter heart valve technologies, with strong secular tailwinds and ...